Study on Cabozantinib to Prevent Progression or Return of High-Risk Pediatric Solid Tumors | Clinical Trial

Study on Cabozantinib to Prevent Progression or Return of High-Risk Pediatric Solid Tumors | Clinical Trial | Right2Hope